Chemicals & Petrochemicals
Sree Rayalaseema Hi-Strength Hypo Limited produces and sells industrial chemicals in India. It operates through three segments: Chemical Manufacturing; Power Generation; and Trading in Coal. The company provides sulphuric, chlorosulphonic, hydrochloric, and monochloro acetic acids; chloramine, purichlor, oleum, sodium dichloroisocyanurate, and hydrogen gas; and aluminum sulphate, stable bleaching powder, sodium hydride, sodium methoxide powder and solution, and water treatment chemicals. It is involved in the generation and distribution of power through thermal, wind, and solar plants; and coal trading business. The company also exports its products. Sree Rayalaseema Hi-Strength Hypo Limited was incorporated in 2005 and is based in Kurnool, India.
Profitability: Recent profitability of 13% is a good sign.
Smart Money: Smart money has been increasing their position in the stock.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Technicals: Bullish SharesGuru indicator.
Balance Sheet: Strong Balance Sheet.
Size: It is a small market cap company and can be volatile.
Growth: Declining Revenues! Trailing 12m revenue has fallen by -42.3% in past one year. In past three years, revenues have changed by -42.1%.
Comprehensive comparison against sector averages
SRHHYPOLTD metrics compared to Chemicals
Category | SRHHYPOLTD | Chemicals |
---|---|---|
PE | 10.66 | 42.95 |
PS | 1.34 | 1.26 |
Growth | -42.3 % | 2.5 % |
SRHHYPOLTD vs Chemicals (2021 - 2025)
Analysis of Sree Rayalaseema Hi-Strength Hypo's financial performance, highlighting revenue trends, growth patterns, and key metrics through quarterly analysis.
Last Updated: Dec 31, 2024
Description | Share | Value |
---|---|---|
Chemicals | 91.7% | 138 Cr |
Unallocated | 8.3% | 12.6 Cr |
Total | 150.6 Cr |
Understand Sree Rayalaseema Hi-Strength Hypo ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
Shareholder Name | Holding % |
---|---|
Gowri Gopal Hospitals Private Limited | 21.8% |
T G V Projects and Investments Private Limited | 15.26% |
Sree Rayalaseema Galaxy Projects Private Limited | 8.82% |
TGV Securities Private Limited | 3.82% |
T G Bharath | 2.92% |
Sree Rayalaseema Dutch Kassenbouw Private Limited | 2.91% |
T G Rajyalakshmi | 2.42% |
T G Shilpa Bharath | 2.31% |
TGV SRAAC Limited | 1.43% |
TGV Industries Private Limited | 0.05% |
Brilliant Industries Private Limited | 0.05% |
Jyothsna S Mysore | 0.04% |
Boda Mourya | 0% |
Distribution across major stakeholders
Distribution across major institutional holders
Valuation | |
---|---|
Market Cap | 917.97 Cr |
Price/Earnings (Trailing) | 10.8 |
Price/Sales (Trailing) | 1.36 |
EV/EBITDA | 7.11 |
Price/Free Cashflow | 9.26 |
MarketCap/EBT | 7.81 |
Fundamentals | |
---|---|
Revenue (TTM) | 675.26 Cr |
Rev. Growth (Yr) | -32.84% |
Rev. Growth (Qtr) | -15.8% |
Earnings (TTM) | 85.02 Cr |
Earnings Growth (Yr) | 29.62% |
Earnings Growth (Qtr) | -14.78% |
Profitability | |
---|---|
Operating Margin | 18.15% |
EBT Margin | 17.41% |
Return on Equity | 9.56% |
Return on Assets | 8.32% |
Free Cashflow Yield | 10.8% |
Investor Care | |
---|---|
Dividend Yield | 1.42% |
Dividend/Share (TTM) | 7 |
Shares Dilution (1Y) | 0.00% |
Diluted EPS (TTM) | 49.54 |
Financial Health | |
---|---|
Current Ratio | 8.65 |
Debt/Equity | 0.00 |
Debt/Cashflow | 17.22 |